Biological functions of decorin in cancer

Chinese Journal of Cancer

Volumn 32, Issue 5, 2013, Pages 266-269

  Bi, Xiu Li ^a   Yang, Wancai ^b,c  

^a LIAONING UNIVERSITY   (China)

^b XINXIANG MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Angiogenesis; Cancer; Decorin; Metastasis; Prognosis; Proliferation; Therapy

Indexed keywords

CARBOPLATIN; DECORIN; GEMCITABINE; PROTEIN P21; PROTEIN P27; UVOMORULIN; VASCULOTROPIN;

ANGIOGENESIS; BREAST CANCER; CANCER GROWTH; CANCER PROGNOSIS; CANCER SURVIVAL; CELL MIGRATION; CELL PROLIFERATION; DISEASE MARKER; DRUG EFFICACY; ENDOTHELIUM CELL; GLIOMA; GROWTH INHIBITION; METASTASIS; NEOPLASM; NONHUMAN; OVARY CANCER; PANCREAS CANCER; PATHOGENESIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; RECEPTOR BINDING; REVIEW; SURVIVAL RATE; TUMOR ANGIOGENESIS; TUMOR CELL;

CELL PROLIFERATION; DECORIN; EXTRACELLULAR MATRIX; HUMANS; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84877296900     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.012.10301     Document Type: Review

References (32)

1. Schaefer L, Iozzo RV. Biological functions of the small leucinerich proteoglycans: from genetics to signal transduction. J Biol Chem, 2008,283:21305-21309.
2. Iozzo RV, Schaefer L. Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycans. FEBS J, 2010,277:3864-3875.
3. Schaefer L, Schaefer RM. Proteoglycans: from structural compounds to signaling molecules. Cell Tissue Res, 2010,339: 237-246.
4. Iozzo RV, Chakrani F, Perrotti D, et al. Cooperative action of germ-lin e mutations in decorin and p53 accelerates lymphoma tumorigenesis. Proc Natl Acad Sci U S A, 1999,96:3092-3097.
5. Bi X, Tong C, Dockendorff A, et al. Genetic deficiency of decorin causes intestinal tumor formation through disruption of intestinal cell maturation. Carcinogenesis, 2008,29:1435-1440.
6. Csordas G, Santra M, Reed CC, et al. Sustained down-regulation of the epidermal growth factor receptor by decorin. A mechanism for controlling tumor growth in vivo. J Biol Chem, 2000,275:32879-32887.
7. Santra M, Eichstetter I, Iozzo RV. An anti-oncogenic role for decorin. Down-re gulation of ErbB2 leads to growth suppression and cytodifferentiation of mammary carcinoma cells. J Biol Chem, 2000,275:35153-35161.
8. Gialeli C, Kletsas D, Mavroudis D, et al. Targeting epidermal growth factor receptor in solid tumors: critical evaluation of the biological importance of therapeutic monoclonal antibodies. Curr Med Chem, 2009,16:3797-3804.
9. Zhu JX, Goldoni S, Bix G, et al. Decorin evokes protracted internalization and degradation of the epidermal growth factor receptor via caveolar endocytosis. J Biol Chem, 2005,280: 32468-32479.
10. Reed CC, Waterhouse A, Kirby S, et al. Decorin prevents metastatic spreading of breast cancer. Oncogene, 2005,24: 1104-1110.
11. Goldoni S, Humphries A, Nystrom A, et al. Decorin is a novel antagonistic ligand of the Met receptor. J Cell Biol, 2009,185: 743-754.
12. Baghy K, Iozzo RV, Kovalszky I. Decorin-TGF-axis in hepatic fibrosis and cirrhosis. J Histochem Cytochem, 2012,60:262-268.
13. Fiedler LR, Schonherr E, Waddington R, et al. Decorin regulates endothelial cell motility on collagen I through activation of insulin-lik e growth factor I receptor and modulation of alpha2beta1 integrin activity. J Biol Chem, 2008,283:17406-17415.
14. de Lange Davies C, Engesaeter BO, Haug I, et al. Uptake of IgG in osteosarcoma correlates inversely with interstitial fluid pressure, but not with interstitial constituents. Br J Cancer, 2001,85:1968-1977.
15. Grant DS, Yenisey C, Rose RW, et al. Decorin suppresses tumor cell-m ediated angiogenesis. Oncogene, 2002, 21:4765-4777.
16. Neill T, Painter H, Buraschi S, et al. Decorin antagonizes the angiogenic network: concurrent inhibition of Met, hypoxia inducible factor 1alpha, vascular endothelial growth factor A, and induction of thrombospondin-1 and TIMP3. J Biol Chem, 2012,287:5492-5506.
17. Bi X, Pohl NM, Qian Z, et al. Decorin-mediated inhibition of colorectal cancer growth and migration is associated with Ecadherin in vitro and in mice. Carcinogenesis, 2012,33:326-330.
18. Buraschi S, Pal N, Tyler-Rubinstein N, et al. Decorin antagonizes Met receptor activity and downre gulatescatenin and Myc levels. J Biol Chem, 2010,285:42075-42085.
19. Wels J, Kaplan RN, Rafii S, et al. Migratory neighbors and distant invaders: tumor-associated niche cells. Genes Dev, 2008,22:559-574.
20. Liang Z, Yoon Y, Votaw J, et al. Silencing of CXCR4 blocks breast cancer metastasis. Cancer Res, 2005,65:967-971.
21. Nash MA, Loercher AE, Freedman RS. In vitro growth inhibition of ovarian cancer cells by decorin: synergism of action between decorin and carboplatin. Cancer Res, 1999,59:6192-6196.
22. Koninger J, Giese NA, di Mola FF, et al. Overexpressed decorin in pancreatic cancer: potential tumor growth inhibition and attenuation of chemotherapeutic action. Clin Cancer Res, 2004,10:4776-4783.
23. Goldoni S, Iozzo RV. Tumor microenvironment: modulation by decorin and related molecules harboring leucine-rich tandem motifs. Int J Cancer, 2008,123:2473-2479.
24. Goldoni S, Seidler DG, Heath J, et al. An antimetastatic role for decorin in breast cancer. Amer J Pathol, 2008,173:844-855.
25. Theocharis AD. Human colon adenocarcinoma is associated with specific post-translational modifications of versican and decorin. Biochim Biophys Acta, 2002,1588:165-172.
26. Tralhao JG, Schaefer L, Micegova M, et al. In vivo selective and distant killing of cancer cells using adenovirus-m ediated decorin gene transfer. FASEB J, 2003,17:464-466.
27. Biglari A, Bataille D, Naumann U, et al. Effects of ectopic decorin in modulating intracranial glioma progression in vivo, in a rat syngeneic model. Cancer Gene Ther, 2004,11:721-732.
28. Smetsers TF, van de Westerlo EM, ten Dam GB, et al. Human single-chain antibodies reactive with native chondroitin sulfate detect chondroitin sulfate alterations in melanoma and psoriasis. J Invest Dermatol, 2004,122:707-716.
29. Yip GW, Smollich M, Gotte M. Therapeutic value of glycosaminoglycans in cancer. Mol Cancer Ther, 2006,5:2139-2148.
30. Troup S, Njue C, Kliewer EV, et al. Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer. Clin Cancer Res, 2003,9:207-214.
31. Matsumine A, Shintani K, Kusuzaki K, et al. Expression of decorin, a small leucine-rich proteoglycan, as a prognostic factor in soft tissue tumors. J Surg Onco, 2007,96:411-418.
32. Mefford D, Mefford J. Stromal genes add prognostic information to proliferation and histoclinical markers: a basis for the next generation of breast cancer gene signatures. PLoS One, 2012,7:e37646.